Patents by Inventor Sunil Kurian

Sunil Kurian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE EXPRESSION PROFILES ASSOCIATED WITH SUB-CLINICAL KIDNEY TRANSPLANT REJECTION
    Publication number: 20240410007
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Application
    Filed: June 24, 2024
    Publication date: December 12, 2024
    Inventors: Daniel Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Todd Ordoukhanian
  • Gene expression profiles associated with sub-clinical kidney transplant rejection
    Patent number: 12060611
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Grant
    Filed: September 12, 2019
    Date of Patent: August 13, 2024
    Assignees: THE SCRIPPS RESEARCH INSTITUTE, NORTHWESTERN UNIVERSITY
    Inventors: Daniel Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries
    Publication number: 20220205042
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Application
    Filed: August 13, 2021
    Publication date: June 30, 2022
    Inventors: Daniel R. Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • Molecular signatures for distinguishing liver transplant rejections or injuries
    Patent number: 11104951
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: August 31, 2021
    Assignees: The Scripps Research Institute, Northwestern University
    Inventors: Daniel Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS
    Publication number: 20200407791
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in kidney biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing kidney transplantation patients who have Acute Rejection (AR), Acute Dysfunction No Rejection (ADNR), Chronic Allograft Nephropathy (CAN), or Transplant Excellent/Normal (TX). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of transplantation patients.
    Type: Application
    Filed: January 24, 2020
    Publication date: December 31, 2020
    Inventors: Daniel R. Salomon, Sunil Kurian, Michael M. Abecassis
  • GENE EXPRESSION PROFILES ASSOCIATED WITH SUB-CLINICAL KIDNEY TRANSPLANT REJECTION
    Publication number: 20200208217
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Application
    Filed: September 12, 2019
    Publication date: July 2, 2020
    Inventors: Daniel Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • Gene expression profiles associated with sub-clinical kidney transplant rejection
    Patent number: 10443100
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: October 15, 2019
    Assignee: The Scripps Research Institute
    Inventors: Daniel R. Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steve Head, Phillip Ordoukhanian
  • TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTION
    Publication number: 20170191128
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in kidney biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing kidney transplantation patients who have Acute Rejection (AR), Acute Dysfunction No Rejection (ADNR), Chronic Allograft Nephropathy(CAN), or Transplant Excellent/Normal (TX). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of transplantation patients.
    Type: Application
    Filed: May 22, 2015
    Publication date: July 6, 2017
    Inventors: Daniel R. Salomon, Sunil Kurian, Michael M. Abecassis
  • MOLECULAR SIGNATURES FOR DISTINGUISHING LIVER TRANSPLANT REJECTIONS OR INJURIES
    Publication number: 20170183735
    Abstract: By a genome-wide gene analysis of expression profiles of known or putative gene sequences in peripheral blood and biopsy samples, the present inventors have identified a consensus set of gene expression-based molecular biomarkers for distinguishing liver transplantation patients who have Acute Rejection (AR), Hepatitis C Virus Recurrence (HCV-R), both AR/HCV-R, or Acute Dysfunction No Rejection (ADNR). These molecular biomarkers are useful for diagnosis, prognosis and monitoring of liver transplantation patients.
    Type: Application
    Filed: May 22, 2015
    Publication date: June 29, 2017
    Inventors: Daniel R. Salomon, Josh Levitsky, Sunil Kurian, Michael Abecassis
  • GENE EXPRESSION PROFILES ASSOCIATED WITH SUB-CLINICAL KIDNEY TRANSPLANT REJECTION
    Publication number: 20170137885
    Abstract: By a genome-wide gene analysis of expression profiles of over 50,000 known or putative gene sequences in peripheral blood, the present inventors have identified a consensus set of gene expression-based molecular biomarkers associated with subclinical acute rejection (subAR). These genes sets are useful for diagnosis, prognosis, monitoring of subAR.
    Type: Application
    Filed: November 22, 2016
    Publication date: May 18, 2017
    Inventors: Daniel R. Salomon, John Friedewald, Sunil Kurian, Michael M. Abecassis, Steven Head, Phillip Ordoukhanian